Investing in the Analytical Methods and Facilities for the Future of Live Biotherapeutic Products

Time: 5:00 pm
day: Day One


As an increasing number of Live Biotherapeutic Products move through clinical trials to commercialization, there is a growing need for
more advanced analytical methods to characterize drug substance and drug product, establish CQAs, and ensure process control.
Facility design is instrumental to product purity and quality and contributes greatly to a smooth regulatory approval. Jeff will share how
Arranta is investing in analytics and facility design to help bring therapies to patients.